Showing results (91-100 of 106) with videos related to
Sort By:
Pageof 11
Cancer Immunology Research|December 8, 2025
A universal boosting strategy for adoptive T cell therapy using a paired vaccine/chimeric antigen receptorRebecca Burchett, Claire G Morris, Mira Ishak, et al.Biorxiv : the Preprint Server for Biology|April 2, 2024
Endogenous CD28 drives CAR T cell responses in multiple myelomaMackenzie M Lieberman, Jason H Tong, Nkechi U Odukwe, et al.Eclinicalmedicine|September 27, 2023
Early Omicron infection is associated with increased reinfection risk in older adults in long-term care and retirement facilitiesJessica A Breznik, Ahmad Rahim, Ali Zhang, et al.Iscience|June 23, 2021
Expanded human NK cells armed with CAR uncouple potent anti-tumor activity from off-tumor toxicity against solid tumorsAna L Portillo, Richard Hogg, Sophie M Poznanski, et al.Molecular Oncology|August 16, 2023
Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non-small cell lung cancer (NSCLC) through inhibition of HIF-1αOlga-Demetra Biziotis, Evangelia Evelyn Tsakiridis, Amr Ali, et al.Journal of Leukocyte Biology|March 4, 2026
HER2-Specific Synthetic Antigen Receptor (SAR) T Cell Therapy Synergizes with Radiotherapy to Provide Improved Anti-Tumor Efficacy in Non-Small Cell Lung Cancer (NSCLC)Olga-Demetra Biziotis, Christopher M Silvestri, Allyson E Moore, et al.Journal of Medical Virology|October 12, 2023
Early humoral and cellular responses after bivalent SARS-CoV-2 mRNA-1273.214 vaccination in long-term care and retirement home residents in Ontario, Canada: An observational cohort studyJessica A Breznik, Ahmad Rahim, Hina Bhakta, et al.Blood|November 20, 2010
CD8+ T-cell expansion and maintenance after recombinant adenovirus immunization rely upon cooperation between hematopoietic and nonhematopoietic antigen-presenting cellsJennifer D Bassett, Teng Chih Yang, Dannie Bernard, et al.Nature Communications|August 5, 2018
The chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicityChristopher W Helsen, Joanne A Hammill, Vivian W C Lau, et al.Blood Cancer Discovery|February 2, 2026
Endogenous CD28 drives the persistent activity of CAR T cells in myeloma and lymphoma modelsMackenzie M Lieberman, Jason H Tong, Nkechi U Odukwe, et al.Pageof 11